Clinical observation of Danhong Injection combined with alteplase in treatment of different types of acute cerebral infarction
Jun HAO,Xin CHEN,Hai-qin WU
DOI: https://doi.org/10.7501/j.issn.1674-5515.2016.09.008
2016-01-01
Abstract:Objective To explore the clinical effect of Danhong Injection combined with alteplase in treatment of different types of acute cerebral infarction. Methods Patients (72 cases) with acute cerebral infarction in Yulin Second Hospital and the Second Affiliated Hospital of Xi’an Jiaotong University from April 2013 to March 2015 were randomly divided into control and treatment groups, and each group had 36 cases. Patients in the control group were iv administered with Alteplase for injection, 0.9 mg/kg, 10%iv bolus injection, 90%iv drip, the infusion is completed within 1 h, and the maximum dose is not more than 90 mg. Patients in the treatment group were iv administered with Danhong Injection on the basis of the control group, 20 mL added into normal saline 250 mL, once daily. Patients in two groups were treated for 2 weeks. After treatment, the clinical efficacies were evaluated, and TCD parameters, TCD blood flow typing, NIHSS scores, and mRS scores in two groups were compared. Results After treatment, the clinical efficacies in the total, partial, and non-occlusion types of the control group were 66.67%, 81.82%, and 94.74%, respectively,and those of the treatment group were 83.33%, 90.00%, and 95.00%, respectively, and there was no difference between two groups. After thrombolysis, Vs, Vm, and Vd in the total and partial occlusion type of the control and treatment groups were increased, but PI in the total and partial occlusion type of the control and treatment groups were decreased, and the difference was statistically significant in the same group (P<0.05). And the observational indexes in the treatment group were significantly better than those in the control group, with significant difference between two groups (P<0.05). After treatment, the proportion of the total and partial occlusion type of the control and treatment groups was decreased, but the proportion of the non-occlusion type of the control and treatment groups was increased, and the difference was statistically significant in the same group (P<0.05). And the observational indexes in the treatment group were significantly better than those in the control group, with significant difference between two groups (P<0.05). After the first and second week treatment, the NIHSS scores of the total, partial, and non-occlusion type of the control and treatment groups were decrease, and the difference was statistically significant in the same group (P<0.05). And the observational indexes in the treatment group were significantly lower than those in the control group, with significant difference between two groups (P<0.05). After 3 months treatment, the mRS scores of the partial and non-occlusion type of the treatment group were significantly decreased, and the difference was statistically significant in the same type (P<0.05). And the mRS score of the non-occlusion type of the treatment group were significantly lower than that in the control group, with significant difference between two groups (P < 0.05). Conclusion Danhong Injection combined with alteplase has clinical curative effect in treatment of different types of acute cerebral infarction, and can improve brain function, promote occluded vessels recanalization, improve hemodynamics, which is beneficial to short-term prognosis, with good safety, which has a certain clinical application value.